Interference-free SERS nanoprobes for labeling and imaging of MT1-MMP in breast cancer cells.
Dan ZhuAnran LiYunsong DiZhuyuan WangJingzhan ShiXiaoqi NiYiping WangPublished in: Nanotechnology (2021)
The expression of membrane type-1 matrix metalloproteinase (MT1-MMP) in cancer cells is critical for understanding the development, invasion and metastasis of cancers. In this study, we devised an interference-free surface-enhanced Raman scattering (SERS) nanoprobe with high selectivity and specificity for MT1-MMP. The nanoprobe was comprised of silver core-silica shell nanoparticle with a Raman reporter tag (4-mercaptobenzonitrile) embedded in the interface. Moreover, the nitrile group in 4-mercaptobenzonitrile shows a unique characteristic peak in the Raman-silent region (1800-2800 cm-1), which eliminates spectral overlapping or background interference in the Raman fingerprint region (500-1800 cm-1). After surface modification with a targeting peptide, the nanoprobe allowed visualization and evaluation of MT1-MMP in breast cancer cells via SERS spectrometry. This interference-free, peptide functionalized SERS nanoprobe is supposed to be conducive to early diagnosis and invasive assessment of cancer in clinical settings.
Keyphrases
- raman spectroscopy
- gold nanoparticles
- breast cancer cells
- cell migration
- label free
- sensitive detection
- living cells
- high resolution
- poor prognosis
- quantum dots
- fluorescent probe
- optical coherence tomography
- squamous cell carcinoma
- magnetic resonance
- squamous cell
- binding protein
- crispr cas
- computed tomography
- cancer therapy
- drug delivery
- molecularly imprinted